NCT00489996View on ClinicalTrials.gov

Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

June 30, 2005

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

gemcitabine

DRUG

cisplatin

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Shanghai

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00489996 - Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer | Biotech Hunter | Biotech Hunter